https://www.selleckchem.com/pr....oducts/scutellarin.h
8-3.5 [P less then .0001]), human epidermal growth factor receptor 2 (HER2)-positive status (HER2+) (OR, 3.6; 95% CI, 2.1-6.1 [P less then .0001]), luminal B/HER2+ subtype (OR, 3.1; 95% CI, 1.9-5.3 [P less then .001]), triple-negative subtype(OR, 2.4; 95% CI, 1.5-4 [P = .001]), and Karnofsky performance status ≤70 (OR, 6.6; 95% CI, 4.5-9.6 [P less then .0001]) were associated with a higher frequency of CNSm. Brain parenchyma was the most common site of CNSm. The median overall survival after a diagnosis of CNSm was 12.2 months (95%
Like
Comment
Share
